• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

TERT Promoter Mutated Follicular Thyroid Carcinomas Exhibit a Distinct microRNA Expressional Profile with Potential Implications for Tumor Progression.

作者信息

Paulsson Johan O, Zedenius Jan, Juhlin C Christofer

机构信息

Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.

Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.

出版信息

Endocr Pathol. 2021 Dec;32(4):513-516. doi: 10.1007/s12022-021-09695-w. Epub 2021 Oct 21.

DOI:10.1007/s12022-021-09695-w
PMID:34676499
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8608760/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e29e/8608760/ed0ed3f8d669/12022_2021_9695_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e29e/8608760/ed0ed3f8d669/12022_2021_9695_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e29e/8608760/ed0ed3f8d669/12022_2021_9695_Fig1_HTML.jpg

相似文献

1
TERT Promoter Mutated Follicular Thyroid Carcinomas Exhibit a Distinct microRNA Expressional Profile with Potential Implications for Tumor Progression.端粒酶逆转录酶（TERT）启动子突变的滤泡性甲状腺癌表现出独特的微小RNA表达谱，对肿瘤进展可能具有潜在影响。
Endocr Pathol. 2021 Dec;32(4):513-516. doi: 10.1007/s12022-021-09695-w. Epub 2021 Oct 21.
2
A Clinical Overview of Telomerase-Associated Aberrancies in Follicular Thyroid Tumors as Diagnostic and Prognostic Markers: Tert Alert!甲状腺滤泡性肿瘤中端粒酶相关异常作为诊断和预后标志物的临床概述：TERT预警！
Scand J Surg. 2020 Sep;109(3):187-192. doi: 10.1177/1457496919850434. Epub 2019 May 26.
3
TERT Promoter Mutation Spatial Heterogeneity in a Metastatic Follicular Thyroid Carcinoma: Implications for Clinical Work-Up.TERT 启动子突变在转移性滤泡状甲状腺癌中的空间异质性：对临床检查的影响。
Endocr Pathol. 2019 Sep;30(3):246-248. doi: 10.1007/s12022-019-09580-7.
4
TERT Immunohistochemistry Is a Poor Predictor of TERT Promoter Mutations and Gene Expression in Follicular Thyroid Carcinoma.端粒酶逆转录酶免疫组化在滤泡性甲状腺癌中对端粒酶逆转录酶启动子突变和基因表达的预测价值不佳。
Endocr Pathol. 2018 Dec;29(4):380-383. doi: 10.1007/s12022-018-9551-6.
5
TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas.TERT 启动子突变是分化型甲状腺癌不良预后的一个主要指标。
J Clin Endocrinol Metab. 2014 May;99(5):E754-65. doi: 10.1210/jc.2013-3734. Epub 2014 Jan 29.
6
TERT promoter mutations in thyroid cancer: a report from a Middle Eastern population.甲状腺癌中的端粒酶逆转录酶（TERT）启动子突变：来自中东人群的报告。
Endocr Relat Cancer. 2015 Dec;22(6):901-8. doi: 10.1530/ERC-15-0396. Epub 2015 Sep 9.
7
MicroRNA expression array identifies novel diagnostic markers for conventional and oncocytic follicular thyroid carcinomas.miRNA 表达谱阵列鉴定出传统和嗜酸细胞滤泡状甲状腺癌的新型诊断标志物。
J Clin Endocrinol Metab. 2013 Jan;98(1):E1-7. doi: 10.1210/jc.2012-2694. Epub 2012 Nov 12.
8
Role of ultrasound in predicting telomerase reverse transcriptase (TERT) promoter mutation in follicular thyroid carcinoma.超声在预测滤泡状甲状腺癌中端粒酶逆转录酶（TERT）启动子突变中的作用。
Sci Rep. 2024 Jul 3;14(1):15323. doi: 10.1038/s41598-024-66351-z.
9
TERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancer.端粒酶逆转录酶（TERT）启动子突变及其与BRAF V600E突变和甲状腺癌侵袭性临床病理特征的关联。
J Clin Endocrinol Metab. 2014 Jun;99(6):E1130-6. doi: 10.1210/jc.2013-4048. Epub 2014 Mar 11.
10
5hmC Immunohistochemistry: A Predictor of Promoter Mutational Status in Follicular Thyroid Carcinoma?5hmC 免疫组化：滤泡状甲状腺癌启动子突变状态的预测指标？
J Histochem Cytochem. 2023 Aug;71(8):451-458. doi: 10.1369/00221554231190437. Epub 2023 Jul 24.

引用本文的文献

1
TERT Amplification a Risk Stratification Marker in Papillary Thyroid Carcinoma, Significantly Correlated with Tumor Recurrence and Survival.端粒酶逆转录酶基因扩增作为甲状腺乳头状癌的风险分层标志物，与肿瘤复发和生存显著相关。
Endocr Pathol. 2025 Apr 24;36(1):15. doi: 10.1007/s12022-025-09853-4.
2
Emerging roles of circular RNAs in regulating the hallmarks of thyroid cancer.环状RNA在调控甲状腺癌特征中的新作用。
Cancer Gene Ther. 2024 Apr;31(4):507-516. doi: 10.1038/s41417-024-00736-0. Epub 2024 Feb 5.
3
DGCR8 Microprocessor Subunit Mutation and Expression Deregulation in Thyroid Lesions.

本文引用的文献

1
miR-195-5p regulates cell proliferation, apoptosis, and invasion of thyroid cancer by targeting telomerase reverse transcriptase.miR-195-5p 通过靶向端粒酶逆转录酶调节甲状腺癌细胞的增殖、凋亡和侵袭。
Bioengineered. 2021 Dec;12(1):6201-6209. doi: 10.1080/21655979.2021.1963908.
2
Whole-genome Sequencing of Follicular Thyroid Carcinomas Reveal Recurrent Mutations in MicroRNA Processing Subunit DGCR8.《甲状腺滤泡癌的全基因组测序揭示了 miRNA 加工亚基 DGCR8 的反复突变》。
J Clin Endocrinol Metab. 2021 Oct 21;106(11):3265-3282. doi: 10.1210/clinem/dgab471.
3
Non-Coding RNAs: Uncharted Mediators of Thyroid Cancer Pathogenesis.
DGCR8 微处理器亚基突变与甲状腺病变中表达失调。
Int J Mol Sci. 2022 Nov 26;23(23):14812. doi: 10.3390/ijms232314812.
4
Integrated Analysis of Altered lncRNA, circRNA, microRNA, and mRNA Expression in Hepatocellular Carcinoma Carrying TERT Promoter Mutations.携带端粒酶逆转录酶（TERT）启动子突变的肝细胞癌中lncRNA、circRNA、microRNA和mRNA表达改变的综合分析
J Hepatocell Carcinoma. 2022 Nov 29;9:1201-1215. doi: 10.2147/JHC.S385026. eCollection 2022.
5
Case report: Large follicular thyroid carcinoma with multiple cervical lymph node metastases.病例报告：伴有多发颈部淋巴结转移的大滤泡性甲状腺癌。
Front Surg. 2022 Aug 23;9:995859. doi: 10.3389/fsurg.2022.995859. eCollection 2022.
6
Overview of the 2022 WHO Classification of Thyroid Neoplasms.2022 年世卫组织甲状腺肿瘤分类概述。
Endocr Pathol. 2022 Mar;33(1):27-63. doi: 10.1007/s12022-022-09707-3. Epub 2022 Mar 14.
非编码RNA：甲状腺癌发病机制中未知的调节因子
Cancers (Basel). 2020 Nov 4;12(11):3264. doi: 10.3390/cancers12113264.
4
Novel role of ASH1L histone methyltransferase in anaplastic thyroid carcinoma.ASH1L 组蛋白甲基转移酶在间变性甲状腺癌中的新作用。
J Biol Chem. 2020 Jun 26;295(26):8834-8845. doi: 10.1074/jbc.RA120.013530. Epub 2020 May 12.
5
GABPA-dependent down-regulation of DICER1 in follicular thyroid tumours.GABPA 依赖性下调滤泡性甲状腺肿瘤中的 DICER1。
Endocr Relat Cancer. 2020 May;27(5):295-308. doi: 10.1530/ERC-19-0446.
6
Poorly differentiated thyroid carcinoma of childhood and adolescence: a distinct entity characterized by DICER1 mutations.儿童和青少年低分化甲状腺癌：一种以 DICER1 突变为特征的独特实体。
Mod Pathol. 2020 Jul;33(7):1264-1274. doi: 10.1038/s41379-020-0458-7. Epub 2020 Jan 14.
7
DGCR8 microprocessor defect characterizes familial multinodular goiter with schwannomatosis.DGCR8 微处理器缺陷特征表现为家族性多发性甲状腺肿伴神经鞘瘤病。
J Clin Invest. 2020 Mar 2;130(3):1479-1490. doi: 10.1172/JCI130206.
8
aberrancies: a screening tool for malignancy in follicular thyroid tumours.异常：滤泡性甲状腺肿瘤恶性肿瘤的筛查工具。
Endocr Relat Cancer. 2018 Jul;25(7):723-733. doi: 10.1530/ERC-18-0050. Epub 2018 Apr 24.
9
TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas.TERT 启动子突变是分化型甲状腺癌不良预后的一个主要指标。
J Clin Endocrinol Metab. 2014 May;99(5):E754-65. doi: 10.1210/jc.2013-3734. Epub 2014 Jan 29.
10
Frequent somatic TERT promoter mutations in thyroid cancer: higher prevalence in advanced forms of the disease.甲状腺癌中频繁的体细胞 TERT 启动子突变：在疾病的晚期形式中更为普遍。
J Clin Endocrinol Metab. 2013 Sep;98(9):E1562-6. doi: 10.1210/jc.2013-2383. Epub 2013 Jul 5.